Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma
Work
Year: 2023
Type: article
Abstract: Glioblastoma (GBM) is a representative malignant brain tumor characterized by a dismal prognosis, with survival rates of less than 2 years and high recurrence rates. Despite surgical resection and sev... more
Source: Biomedicines
Cites: 60
Cited by: 5
Related to: 10
FWCI: 1.9
Citation percentile (by year/subfield): 77.45
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,382